Drawing for Serial No. 74211260

USPTO serial 74211260

Serial No. 74211260

Reviewed by CopyMark Law Group

Status 614
Filing date
Status date
Registration date
—
Examiner
GOODPASTER, SCOTT
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 74211260?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert W. Snyder

ROBERT W SNYDER940 W 17TH ST STE FSANTA ANA, CA 92706UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical productsABANDONEDSep 21, 1989

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 28, 1993PETDPETITION TO REVIVE-DENIED—
Jun 8, 1993PILMPETITION INQUIRY LETTER ISSUED—
Jan 25, 1993PETRPETITION TO REVIVE-RECEIVED—
Sep 29, 1992ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 13, 1992CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 1991DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance